Search - tctmd.com

Displaying 21 - 32 of 32

Sort: Relevancy | Date

News Industry News

VENITI® Completes First Use Of VICI VERTO VENOUS STENT™, Novel Venous Stent System

April 22, 2016

News Industry News

Endurant AAA Stent Graft System from Medtronic Delivers Consistently Strong Results in Abdominal Aortic Aneurysms with Short and Standard 'Neck' Lengths

April 29, 2015

News Industry News

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

April 28, 2015

News Industry News

Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study

November 03, 2014

News Industry News

Endurant AAA Stent Graft from Medtronic Continues Exceptional Long-Term Performance in Observational Studies

April 18, 2014

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

News Industry News

Medtronic Receives ‘CE’ Mark for Sentrant Introducer Sheath, Complementing Market-Leading Aortic Stent Grafts

April 04, 2013

News Daily News

La Reparación Endovascular Aumenta la Supervivencia de Pacientes con Roturas de AAA

January 22, 2013

News Daily News

Endovascular Repair Ups Survival of Patients with Ruptured AAA

January 22, 2013

News Industry News

Medtronic Announces Global Drug-Eluting Balloon Study

April 17, 2012

News Industry News

Medtronic Endurant® AAA Stent Graft Shows Durable Performance at Two Years in U.S. Study

April 16, 2012

News Industry News

Advertisement

VENITI® Completes First Use Of VICI VERTO VENOUS STENT™, Novel Venous Stent System

Endurant AAA Stent Graft System from Medtronic Delivers Consistently Strong Results in Abdominal Aortic Aneurysms with Short and Standard 'Neck' Lengths

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study

Endurant AAA Stent Graft from Medtronic Continues Exceptional Long-Term Performance in Observational Studies

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

Medtronic Receives ‘CE’ Mark for Sentrant Introducer Sheath, Complementing Market-Leading Aortic Stent Grafts

La Reparación Endovascular Aumenta la Supervivencia de Pacientes con Roturas de AAA

Endovascular Repair Ups Survival of Patients with Ruptured AAA

Medtronic Announces Global Drug-Eluting Balloon Study

Medtronic Endurant® AAA Stent Graft Shows Durable Performance at Two Years in U.S. Study

Medtronic Drug-Coated Balloon (DCB) Demonstrates Consistent Results in Two New Analyses of Complex PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content